The Concept of Old Age
- 806.449
- 0.0000.00%
Peking promotes the large-scale deployment of 10,000 embodied Siasun Robot&Automation, with policy support accelerating industry development.
The "Peking Embodied Asia Vets Technology Innovation and Industry Cultivation Action Plan (2025-2027)" was officially released in Peking. The "Action Plan" states that by 2027, efforts will aim to implement the large-scale deployment of ten thousand embodied Siasun Robot&Automation units and cultivate a trillion-level industrial cluster.
Building a high-frequency communication platform, the "Shanghai Lujiazui Finance & Trade Zone Development Salon" is about to launch with exciting events happening weekly.
① In response to the Shanghai Lujiazui Finance & Trade Zone Development Forum, build an integrated ecosystem of "Global Strategy - Execution." ② The first event on March 1 will focus on "Opportunities and Challenges: Great Power Game, Exchange Rates, and the Construction of the Shanghai International Financial Center."
The final ruling has changed! Innovative Medical Management has revised its 2024 performance forecast, with the company accumulating losses of nearly 1.8 billion over six years | Interpretations
① Only a month after the performance forecast for 2024 was disclosed, Innovative Medical Management has revised its performance forecast, with net losses expanding to 0.1 billion yuan - -85 million yuan; ② Innovative Medical Management had made relevant risk warnings in its performance forecast, and the dispute case between Qianhai Excellence and Jianhua Hospital has been heard but not yet ruled; ③ Since 2019, Innovative Medical Management has reported losses for six consecutive years, with a cumulative loss amounting to nearly 1.8 billion yuan.
The delay in hospital bidding combined with an increase in research and development costs has led to a decline of over fifty percent in Xiangyu Medical's net profit in 2024.
① Xiangyu Medical expects that by 2025 all expenses can be stably controlled, and the company's Net income will return to a growth trend. Mental health products have already met the marketable conditions outside hospitals, and proactive training products are expected to obtain registration certificates by 2025; ② In January 2025, Xiangyu Medical added two new training products that received CE certification, and it is expected that two therapeutic products will obtain certification by mid-2025.
The Robot Concept is experiencing explosive growth! The strongest stock has risen nearly 7 times, and these stocks have all reached new historical highs.
YuTree Technology's Wang Xingxing recently stated that by the end of this year, the entire humanoid robot in the field of AI will reach a new level.
Siasun Robot&Automation is the most critical equipment link, and the dexterous hand market is expected to usher in a period of explosive growth.
The rapid development of the humanoid robot industry will create incremental demand for the dexterous hand market. According to predictions from the Toubao Research Institute, it is expected that in a conservative scenario, the global market size for humanoid robot dexterous hands will reach 32.06 billion yuan by 2030, with a compound annual growth rate of 81.2%. In an optimistic scenario, it could reach 87.97 billion yuan, with a compound annual growth rate of 109.3%.
The DeepSeek large model promotes cost reduction and efficiency improvement, and AI Education products are expected to accelerate commercialization.
① Education is one of the core scenarios for the application of AI. The use of AI technology to reduce costs and increase efficiency makes it possible for education to balance high quality, inclusiveness, and personalization, and is expected to deeply empower education by improving delivery efficiency and enhancing personalized experiences for students. ② The domestic AI + education B2B and B2C markets are expected to reach 47.7 billion yuan and 28.2 billion yuan respectively by 2027, while the AI + companionship market is anticipated to reach a trillion level within 3-5 years.
This week, 11 more companies have been added! Youngor Group and several other stocks have disclosed their plans for shareholding and repurchase loans, with a complete list of related A-shares.
① The Share Buyback and Shareholding refinancing plan in the A-share market is steadily advancing. According to incomplete statistics from Caixin, 11 A-share listed companies announced and disclosed relevant information on Share Buyback and Shareholding refinancing this week (see attached table); ② Youngor Group has the highest special loan amount, totaling 0.7 billion yuan.
Huawei will release AI pathology models, and the Medical Industry is迎来 an important opportunity for intelligent upgrades.
① Huawei's data storage public account released information stating that it will launch the Ruijin pathological model based on the Huawei DCS AI solution. ② Jianghai Securities pointed out that under the guidance of the Health China 2030 Global Strategy, the Medical Industry is ushering in an important opportunity for intelligent upgrades.
Private real estate companies' bond financing broke through, with bond issuance in January increasing by 8.2 percentage points compared to the previous month.
According to data released today by the China Index Academy, a total of four private and mixed-ownership real estate companies completed the issuance of credit bonds in January, namely Greentown, Hangzhou Binjiang Real Estate Group, MIDEA REAL EST, and New Hope Liuhe, with a total issuance amount of 3.9 billion yuan; Additionally, according to monitoring data from E-Han Think Tank, in January of this year, the bond issuance scale of private real estate companies accounted for 8.2% of the total issuance, an increase of 8.2 percentage points month-on-month.
A major reveal of A-share performance in 2024: China Life Insurance earns over 100 billion to claim the title of 'Profit King', and the list of the top 20 pre-profit stocks is here.
① The performance forecast disclosure for A-share listed companies for 2024 has concluded, with China Life Insurance earning a whopping 112.6 billion yuan and claiming the title of "profit king"; ② Attached is the list of the top 20 stocks by performance profit for the 2024 annual report (attached table).
Under the new accounting standards, performance fluctuations have increased! New China Life Insurance turned a loss into profit year-on-year in the fourth quarter of last year, but performance dropped sharply compared to the previous quarter.
①The net income for 2024 is expected to increase from 23.958 billion yuan to 25.7 billion yuan, a year-on-year growth of 175% to 195%; ②In the first three quarters of 2024, New China Life Insurance's investment income and fair value change income totaled 47.119 billion yuan; ③With the recovery of the capital markets and the increase in the proportion of equity asset allocation, New China Life Insurance's investment returns have surged.
Is the industry leader also under pressure? Poly Developments and Holdings Group's performance declines in 2024, initiating structural adjustments.
Poly Developments and Holdings Group recently announced adjustments to its organizational structure, mainly involving the merger of regional companies and personnel changes; before and after this restructuring by Poly Developments and Holdings Group, it coincides with the announcement of a decline in revenue and net profit for 2024.
Youngor Group acquires the "Hermès of children's clothing."
Returning to the fashion main business.
In 2024, a net loss is anticipated to exceed 0.6 billion; Hangzhou Century resorts to selling land to "ease its troubles" after financial fraud | Interpretations
① Hangzhou Century expects a net income loss attributable to shareholders of the listed company of 0.419 billion yuan to 0.629 billion yuan for the fiscal year 2024, with narrowing losses; ② Hangzhou Century was heavily fined by regulators for fabricating false content in the 2019 and 2020 annual reports as well as in the 2021 Convertible Bonds public issuance documents; ③ To alleviate cash flow issues, the company plans to sell assets.
The seasonal influenza A has entered the epidemic period, and the sales of related Chinese Patent Medicine products have significantly increased.
① Recently, the positive rate of influenza virus has significantly increased, with over 99% being type A influenza. Market data shows a clear increase in the demand for various Traditional Chinese Medicine cold medicine products. ② Today, stock prices of several listed companies in the Traditional Chinese Medicine Industry, such as Shanxi Zhendong Pharmaceutical, Hainan Huluwa Pharmaceutical Group, and Zhongsheng Pharmaceutical, have reached the daily limit, with the Traditional Chinese Medicine Sector overall rising, and the Traditional Chinese Medicine 50 ETF increasing by 3.21%.
Saudi ACWA's new milestone: Installed capacity of renewable energy projects in China has exceeded 1GW.
① The Saudi Wind Power giant ACWA announced that its renewable energy projects in China have a total installed capacity exceeding 1GW; ② These projects include wind power and photovoltaic projects, which are wholly or jointly owned by ACWA.
Four executives have new positions, and Ping An Insurance has made adjustments to some executive roles.
Fu Xin also serves as the Chief Financial Officer, Fang Fang concurrently acts as the Chief Risk Officer, and Zhang Zhichun takes on the role of General Assistant and is responsible for auditing.
Rescue or 'bottom fishing'? Four insurance companies have acquired 15 Wanda Assets this year.
New China Life Insurance (601336.SH) has taken over another Wanda Assets. According to Tianyancha information, Wanda Plazas in Chifeng and Jinjiang have already occurred...
As the Spring Festival holiday approaches, the tourism Industry is expected to pick up, and these Concept stocks are frequently being investigated.
The Spring Festival holiday is from January 28 to February 4, 2025, totaling 8 days.